Sartorius Stedim Biotech S.A.

€225.80As of Sun 8 Nov 2026, 12:00 UTC
EPA:DIMHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR 14.33%
Div yield 0.31%
ROE 7.69%
Medical Instruments & Supplies
Beta (5Y) 1.18
PE TTM 67.80
TSR TTM 9.42%
Mkt cap €21.97B
ROIC 6.50%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€273
20.76%
(93.82%)
Hold 2|0|3|7|9
4Q25
1Q26
2Q26
3Q26
Earnings per share€
3.60
3.47
3.81
4.21
17.58%
7.70%
17.07%
18.19%
Revenue€B
1.150
1.207
1.175
1.165
13.54%
13.13%
5.79%
1.91%
Peers (US$24.67B)
Cap (US$)
PE
14.61B
25.72x
12.33B
23.92x
27.85B
44.91x
Capital
TTM
5Y
10Y
Leveragex
0.688
0.090
0.079
EBIT/Intx
0.408
0.181
0.154
Own earn%
6.46
(22.18)
(41.52)
Sh yield%
26.88
45.70
42.70
Owners
Insiders/Inst%
1.00
56.70
Short interest%
3.14
SBC / revenue%
1.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
9–13
$1 testx
0.0
Incr. ROIC%
10